Vanguard Group
MXCT icon

Vanguard Group’s MaxCyte MXCT Stock Holding History

Vanguard Group’s Portfolio MXCT Stock Details MXCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$8.59M Sell
5,539,260
-48,833
-0.9% -$78K ﹤0.01% 3036
2025
Q3 		$8.83M Sell
5,588,093
-13,587
-0.2% -$23.6K ﹤0.01% 3042
2025
Q2 		$12.2M Buy
5,601,680
+36,015
+0.6% +$87.2K ﹤0.01% 2797
2025
Q1 		$15.2M Buy
5,565,665
+135,984
+3% +$536K ﹤0.01% 2627
2024
Q4 		$22.6M Sell
5,429,681
-345,587
-6% -$1.31M ﹤0.01% 2528
2024
Q3 		$22.5M Buy
5,775,268
+130,146
+2% +$548K ﹤0.01% 2536
2024
Q2 		$22.1M Buy
5,645,122
+298,010
+6% +$1.28M ﹤0.01% 2521
2024
Q1 		$22.4M Buy
5,347,112
+65,004
+1% +$305K ﹤0.01% 2546
2023
Q4 		$24.8M Buy
5,282,108
+243,261
+5% +$947K ﹤0.01% 2498
2023
Q3 		$15.7M Buy
5,038,847
+67,917
+1% +$273K ﹤0.01% 2649
2023
Q2 		$22.8M Buy
4,970,930
+82,457
+2% +$379K ﹤0.01% 2538
2023
Q1 		$24.2M Buy
4,888,473
+40,356
+0.8% +$199K ﹤0.01% 2512
2022
Q4 		$26.5M Buy
4,848,117
+182,797
+4% +$1.12M ﹤0.01% 2493
2022
Q3 		$30.3M Buy
4,665,320
+1,269,810
+37% +$7.08M ﹤0.01% 2430
2022
Q2 		$16.1M Buy
3,395,510
+110,914
+3% +$546K ﹤0.01% 2751
2022
Q1 		$23M Buy
3,284,596
+126,906
+4% +$866K ﹤0.01% 2689
2021
Q4 		$32.2M Buy
3,157,690
+403,373
+15% +$4.33M ﹤0.01% 2592
2021
Q3 		$33.6M Buy
+2,754,317
New +$41.5M ﹤0.01% 2581

Other funds holding MXCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
VP
Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
MA
Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Vanguard Group's MXCT Position: Q4 2025 in Review

Vanguard Group reduced its MaxCyte (MXCT) stake by 0.87% in Q4 2025, selling an estimated $78K and leaving 5,539,260 shares worth $8.59M. The position accounts for ﹤0.01% of the portfolio, ranked #3036.

Vanguard Group first reported a position in MXCT in Q3 2021 and has held it in 18 quarters since. The position peaked at $33.6M in Q3 2021. 112 funds tracked by Wall St. Rank hold MXCT as of Q4 2025.

  • Vanguard Group held 5,539,260 shares of MaxCyte worth $8.59M as of Q4 2025.
  • Vanguard Group sold 48,833 MaxCyte shares in Q4 2025, an estimated $78K.
  • MaxCyte made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3036 holding.
  • Vanguard Group first reported a position in MaxCyte in Q3 2021 and has held it in 18 quarters since.
  • Vanguard Group's MaxCyte position peaked at $33.6M in Q3 2021.
  • 112 funds tracked by Wall St. Rank held MaxCyte as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.